{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:58:58Z","timestamp":1785383938784,"version":"3.55.0"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":209,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274582"],"award-info":[{"award-number":["82274582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunology Research"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>In order to investigate the therapeutic mechanism of Jianpiyiqi Granule in juvenile myasthenia gravis (JMG) and find the immune\u2010associated cytokines or signaling pathways targeted by this intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>(1) We extracted JMG serum samples from the sample bank of the Hebei Provincial Key Laboratory of Myasthenia Gravis before and after treatment. (2) Using Olink Immune Response Panel detects serum cytokines. Data were collated and analyzed using statistical software. Differentially expressed proteins (DEPs) were visualized using heat maps, volcano plots, and other tools. Differentially expressed cytokines were analyzed using KEGG enrichment pathway analysis to identify the relevant signaling pathways they participate in.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      (1) Twelve of 92 cytokines were found to be differentially expressed from 20 patients before and after treatment, namely AXIN1, CCL11, CCL13, CCL20, CCL25, CCL3, CD40, IL12B, S100A12, SIRT2, SLAMF1, and STAMBP (|log\n                      <jats:sub>2<\/jats:sub>\n                      FC|\u2009&gt;\u20090.263; false discovery rate (FDR)\u2010adjusted\n                      <jats:italic>p<\/jats:italic>\n                      \u2009 &lt; 0.05). IL12B was upregulated while AXIN1, CCL11, CCL13, CCL20, CCL25, CCL3, CD40, S100A12, SIRT2, SLAMF1 and STAMBP were downregulated after treatment. Notably, three of these\u2014CCL11, IL12B, and STAMBP\u2014showed stronger statistical evidence, with FDR\u2010adjusted\n                      <jats:italic>p<\/jats:italic>\n                      \u2009 &lt; 0.01 and |log\n                      <jats:sub>2<\/jats:sub>\n                      FC|\u2009&gt;\u20090.263. (2) The following pathways were obtained by KEGG enrichment analysis of 12 cytokines: cytokine\u2013cytokine receptor interaction, viral protein interaction with cytokine and cytokine receptor, chemokine signaling pathway, Toll\u2010like receptor (TLR) signaling pathway, intestinal immune network for IgA production, IL\u201017 signaling pathway, NF\u2010kappa B signaling pathway. (3) CCL11 and CCL20 were enriched in the IL\u201017 signaling pathway. We used enzyme\u2010linked immunosorbent assay (ELISA) to retest additional serum samples before and after treatment from 12 JMG patients before and after treatment. The results showed a significant decrease in CCL11 and CCL20 in after\u2010treatment serum (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009 &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Drug therapy for JMG revealed 12 differentially expressed cytokines. Due to the exploratory nature and sample volume constraints, only two candidate cytokines were validated by ELISA. We found that the cytokines CCL11 and CCL20\u2014associated with the IL\u201017 signaling pathway\u2014were downregulated after treatment. The drug therapy may inhibit MG progression by reducing the expression of IL\u201017\u2010associated cytokines. At the same time, the drug reduced the expression of CCL3, CCL13, CCL25, and CD40, which may play a role in the abnormal proliferation of thymocytes and chronic inflammatory response at the neuromuscular junction. Future studies with multiplex assays are needed to confirm the involvement of other differentially expressed cytokines, such as SIRT2 and AXIN1, which may contribute to disease mechanisms outside the identified pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/jimr\/3929690","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:08:53Z","timestamp":1785380933000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytokine Changes With Effective Drug Therapy for Juvenile Myasthenia Gravis"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4922-0867","authenticated-orcid":false,"given":"Yuanyuan","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9218-3219","authenticated-orcid":false,"given":"Guoyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7504-757X","authenticated-orcid":false,"given":"Xiaoting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4998-668X","authenticated-orcid":false,"given":"Yousheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"e_1_2_13_1_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011124"},{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002790"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.001"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20030"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.03.004"},{"key":"e_1_2_13_6_2","first-page":"5","article-title":"Analysis of Clinical Characteristics of Adolescent - Onset Myasthenia Gravis Patients","volume":"23","author":"Fan L.","year":"2016","journal-title":"Chinese Journal of Neuroimmunology and Neurology"},{"key":"e_1_2_13_7_2","unstructured":"WangH. SuZ. andLiuW. Effects of Thymectomy and Hormone Therapy on Bone Age and Height Development in Adolescent Patients With Myasthenia Gravis Proceedings of the 2013 Shandong Provincial Academic Conference on Neurology and the 2013 Chinese Conference on Neuroimmunology 2013."},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.13193\/j.issn.1673-7717.2017.03.031"},{"key":"e_1_2_13_9_2","first-page":"60","article-title":"Visual Analysis of Traditional Chinese Medicine in the Treatment of Myasthenia Gravis Based on CiteSpace","volume":"17","author":"Wang J.","year":"2025","journal-title":"Clinical Journal of Chinese Medicine"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2021.100806"},{"key":"e_1_2_13_11_2","first-page":"1","article-title":"Chinese Guidelines for the Diagnosis and Treatment of Myasthenia Gravis (2020 Edition)","volume":"28","author":"Chang T.","year":"2021","journal-title":"Chinese Journal of Neuroimmunology and Neurology"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(00)01595-2"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0254-6272(17)30162-0"},{"key":"e_1_2_13_14_2","first-page":"905","article-title":"Reliability and Validity Evaluation of the Myasthenia Gravis Muscle Group Endurance Rating Scale","volume":"41","author":"Qi G.","year":"2020","journal-title":"Journal of Hebei Medical University"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.36"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1728767"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.2853"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05823-w"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.01.012"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102800"},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084115"},{"key":"e_1_2_13_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04271-9"},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1082565"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03486-4"},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.14126\/j.cnki.1008-7044.2024.06.017"},{"key":"e_1_2_13_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1034737"},{"key":"e_1_2_13_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.05.008"},{"key":"e_1_2_13_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1624957"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1812"},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242545"},{"key":"e_1_2_13_31_2","first-page":"438","article-title":"Associated Factors of Thymic Hyperplasia in Children With Myasthenia Gravis","volume":"42","author":"Guiming H.","year":"2013","journal-title":"Acta Medica Universitatis Scientiae et Technologiae Huazhong"},{"key":"e_1_2_13_32_2","doi-asserted-by":"publisher","DOI":"10.5607\/en.2016.25.1.40"},{"key":"e_1_2_13_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1648020"}],"container-title":["Journal of Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/jimr\/3929690","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/jimr\/3929690","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/jimr\/3929690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:08:58Z","timestamp":1785380938000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/jimr\/3929690"}},"subtitle":[],"editor":[{"given":"Poorani","family":"Gurumallesh Prabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/jimr\/3929690"],"URL":"https:\/\/doi.org\/10.1155\/jimr\/3929690","archive":["Portico"],"relation":{},"ISSN":["2314-8861","2314-7156"],"issn-type":[{"value":"2314-8861","type":"print"},{"value":"2314-7156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-11-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"3929690"}}